Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Rheumatology Physician in Pasadena, CA
NPI: 1427255454Primary Employer
The Huntington Medical Foundation
huntingtonhealth.org
HQ Phone
Get M.D. Darice's Phone Numberphone_androidMobile
Get M.D. Darice's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2025
American Board of Internal Medicine
Rheumatology
Lewis Katz School of Medicine
medicine.temple.edu
Medical School
Until 2004
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Fellowship • Rheumatology
2008 - 2010
Residency • Internal Medicine
2004 - 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 111 | 286 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 39 | 55 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 20 | 33 |
| 4 | J0897Injection, denosumab, 1 mg | 20 | 1,920 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 14 | 16 |
Genetic Variants of DNA Repair-Related Genes Predict Efficacy of TAS-102 in Patients with Refractory Metastatic Colorectal Cancer
Authors: Afsaneh Barzi
Impact of Genetic Variations in the MAPK Signaling Pathway on Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI and Bevacizumab: Data from FIRE-3 and TRIBE Trials
Authors: Darice Yang, MD
Lead Sponsor: Sandoz
Intervention / Treatment: DRUG: GP2015